] As of Mar. 21 10:10 A.M., Kwangdong Pharmaceutical slightly edged up 0.8% to 8,780 won (US$7.87). It had declined 3.09% through the past month. Standard deviation, the risk index for stock price, was 1.3% on the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, Kwangdong Pharmaceutical was not only satisfactory in investment return among its peer group, but its volatility was also the lowest. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -2.3%. Compared with the KOSPI industry, the return-on-risk is below the industrial mean, 7.5, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (firstname.lastname@example.org
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.